Browsing by Author "Aranda Aguilar, Enrique"
Now showing items 1-5 of 5
-
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Borrero-Palacios, Áurea; Cebrián, A; Gómez Del Pulgar, MT; García, P; Elez Fernandez, Mª Elena; Garcia-Carbonero, Rocio; Aranda Aguilar, Enrique (Nature Research, 2019-02-22) -
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
Vivancos Prellezo, Ana; Benavides, Manuel; Elez Fernandez, Mª Elena; Gómez-España, Maria Auxiliadora; Toledano, Marta; Aranda Aguilar, Enrique (Nature Research, 2019-06-20) -
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept
González Astorga, B.; Salva Ballabrera, Francesc; Elez Fernandez, Mª Elena; García‑Alfonso, P.; González Flores, E.; Aranda Aguilar, Enrique (Springer, 2021-08) -
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
Fernández Montes, Ana; Alonso, Vicente; Aranda Aguilar, Enrique; Grávalos, Cristina; Elez, Elena; García-Alfonso, Pilar (Springer, 2023-09) -
Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain
Rodríguez‑Lescure, A.; de la Peña, F. A.; Calvo, A.; Felip Font, Enriqueta; Garrido, Pilar; Aranda Aguilar, Enrique (Springer, 2020-12)